SCHEMBL8501291

SCHEMBL8501291

O=c1ccc2cc(-c3ccsc3)cnc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 10/20 0.51
▸ PDGFRA P16234 10/20 0.51
▸ AXL P30530 1/20 0.45
▸ CYP2A6 P11509 3/20 0.45
▸ MET P08581 1/20 0.42
▸ CDK8 P49336 1/20 0.42
▸ CCNT1 O60563 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ CDK9 P50750 1/20 0.42
▸ CYP2E1 P05181 1/20 0.41
▸ CYP2B6 P20813 1/20 0.41
▸ EEF2K O00418 1/20 0.40
▸ DYRK3 O43781 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ RPS6KA5 O75582 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ PIM1 P11309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11804721 0.79 PIK3CG (0.58) PDGFRBPDGFRAAXLCDK8PIK3CG
SCHEMBL28823561 0.78 CDK8 (0.58) PDGFRBPDGFRAAXLMETCDK8
SCHEMBL857007 0.77 PIK3CD (0.64) PDGFRBPDGFRAAXLCYP2A6CDK8
SCHEMBL16144853 0.77 PDE3B (0.37) PDGFRBPDGFRACYP2A6CYP2E1CYP2B6
SCHEMBL29930506 0.75 PDGFRB (0.55) PDGFRBPDGFRAAXLCYP2A6CDK8
SCHEMBL4283899 0.74 CA12 (0.49) PDGFRBPDGFRACDK5PDE3BPDE3A
SCHEMBL8501275 0.72 PDGFRB (0.50) PDGFRBPDGFRACDK1PDE3BPDE3A
SCHEMBL10725775 0.71 PDE3B (0.44) AXLCDK8CDK2DYRK3JAK2
SCHEMBL20660063 0.70 NPC1 (0.57) PDGFRBPDGFRACYP2A6DYRK1A
SCHEMBL1252408 0.69 AURKA (0.49) PDGFRBPDGFRAMETCDK8CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 — — US disclosed
US-5656643-A QUINOLIN PYRIDINE DERIVATIVES; USEFUL FOR TREATING CANCER, LEKEMIA, PSORIASIS, INFLAMMATORY DISODERS, BONE DISORDERS, ATHEROSCLEROSIS AND RESTENOSIS; CONTROLLS CELLULAR REPRODUCTION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-08-12 — — US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 — — US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 — — US disclosed
US-5409930-A Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-04-25 — — US disclosed
WO-1992020642-A1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-11-26 — — WO disclosed
Send feedback